<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>6(4)</volume><submitter>Olsson Magi CA</submitter><funding>Vetenskapsrådet</funding><funding>Vårdalstiftelsen</funding><funding>Karolinska Institutet SFO-V</funding><funding>The Norwegian Research Council</funding><funding>Oslo University Hospital</funding><funding>Universitetet i Oslo</funding><funding>The Regional Health Board South East</funding><funding>Health and Rehabilitation Norway</funding><funding>Konsul Th. C Bergh Foundation</funding><funding>Sykehuset Østfold</funding><funding>Hjärt-Lungfonden</funding><funding>Astma- och Allergiförbundet</funding><funding>Hesselman&amp;apos;s Research</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>Maternal stress during pregnancy may negatively affect the health of mother and child. We therefore aimed to identify the proportion of women reporting high maternal stress in mid and late pregnancy and explore whether symptoms of maternal allergic disease are associated with perceived maternal stress in late pregnancy.&lt;h4>Method&lt;/h4>The population-based Preventing Atopic Dermatitis and Allergy in Children (PreventADALL) study enrolled 2697 pregnant women at their 18-week routine ultrasound examination in Norway and Sweden. Information about sociodemographic factors, symptoms and doctor-diagnosed asthma, allergic rhinitis, atopic dermatitis, food allergy, and anaphylaxis and stress using the 14-item perceived stress scale (PSS) was collected at 18 weeks (mid) and 34 week</pubmed_abstract><journal>ERJ open research</journal><pagination>00175-2020</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7553112</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Allergic disease and risk of stress in pregnant women: a PreventADALL study.</pubmed_title><pmcid>PMC7553112</pmcid><pubmed_authors>Staff AC</pubmed_authors><pubmed_authors>Nordlund B</pubmed_authors><pubmed_authors>Lodrup Carlsen OC</pubmed_authors><pubmed_authors>Haugen G</pubmed_authors><pubmed_authors>Soderhall C</pubmed_authors><pubmed_authors>Olsson Magi CA</pubmed_authors><pubmed_authors>Bjerg Backlund A</pubmed_authors><pubmed_authors>Jonassen CM</pubmed_authors><pubmed_authors>Lodrup Carlsen K</pubmed_authors><pubmed_authors>Rehbinder EM</pubmed_authors><pubmed_authors>Carlsen KH</pubmed_authors><pubmed_authors>Sjoborg KD</pubmed_authors><pubmed_authors>Granum B</pubmed_authors><pubmed_authors>Almqvist C</pubmed_authors><pubmed_authors>Vettukattil R</pubmed_authors><pubmed_authors>Hilde K</pubmed_authors><pubmed_authors>Skjerven H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Allergic disease and risk of stress in pregnant women: a PreventADALL study.</name><description>&lt;h4>Background&lt;/h4>Maternal stress during pregnancy may negatively affect the health of mother and child. We therefore aimed to identify the proportion of women reporting high maternal stress in mid and late pregnancy and explore whether symptoms of maternal allergic disease are associated with perceived maternal stress in late pregnancy.&lt;h4>Method&lt;/h4>The population-based Preventing Atopic Dermatitis and Allergy in Children (PreventADALL) study enrolled 2697 pregnant women at their 18-week routine ultrasound examination in Norway and Sweden. Information about sociodemographic factors, symptoms and doctor-diagnosed asthma, allergic rhinitis, atopic dermatitis, food allergy, and anaphylaxis and stress using the 14-item perceived stress scale (PSS) was collected at 18 weeks (mid) and 34 week</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Oct</publication><modification>2026-04-30T05:07:12.4Z</modification><creation>2020-10-29T12:37:11Z</creation></dates><accession>S-EPMC7553112</accession><cross_references><pubmed>33083440</pubmed><doi>10.1183/23120541.00175-2020</doi></cross_references></HashMap>